To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects
Clinical trial NCT02462031 · UNKNOWN
Trial details
- NCT number
- NCT02462031
- Sponsor
- Kwang Dong Pharmaceutical co., ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2016-01-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.